The growing popularity of semaglutide-based weight-loss and diabetes medicines in India is now driving a sharp rise in demand for vitamin and nutritional supplements, according to doctors and pharmaceutical market trackers.
Just weeks after generic versions of semaglutide, the active ingredient associated with medicines such as Ozempic, entered the Indian market, clinicians say more patients using GLP-1 receptor agonist drugs are being advised to take multivitamins, protein supplements and minerals to avoid nutritional deficiencies.
